###begin article-title 0
European lactase persistence genotype shows evidence of association with increase in body mass index
###end article-title 0
###begin p 1
###xml 342 345 342 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 945 946 942 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 957 959 954 956 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
The global prevalence of obesity has increased significantly in recent decades, mainly due to excess calorie intake and increasingly sedentary lifestyle. Here, we test the association between obesity measured by body mass index (BMI) and one of the best-known genetic variants showing strong selective pressure: the functional variant in the cis-regulatory element of the lactase gene. We tested this variant since it is presumed to provide nutritional advantage in specific physical and cultural environments. We genetically defined lactase persistence (LP) in 31 720 individuals from eight European population-based studies and one family study by genotyping or imputing the European LP variant (rs4988235). We performed a meta-analysis by pooling the beta-coefficient estimates of the relationship between rs4988235 and BMI from the nine studies and found that the carriers of the allele responsible for LP among Europeans showed higher BMI (P = 7.9 x 10-5). Since this locus has been shown to be prone to population stratification, we paid special attention to reveal any population substructure which might be responsible for the association signal. The best evidence of exclusion of stratification came from the Dutch family sample which is robust for stratification. In this study, we highlight issues in model selection in the genome-wide association studies and problems in imputation of these special genomic regions.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 18 21 18 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LCT</italic>
###xml 599 602 599 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 629 632 629 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LCT</italic>
###xml 829 835 829 835 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-13910</sub>
###xml 880 885 880 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 888 889 888 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C1">1</xref>
###xml 1116 1119 1116 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LCT</italic>
###xml 1143 1144 1143 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C2">2</xref>
###xml 1145 1146 1145 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C3">3</xref>
###xml 1208 1216 1208 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1218 1219 1218 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C4">4</xref>
###xml 1220 1221 1220 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C5">5</xref>
###xml 1323 1324 1323 1324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C6">6</xref>
###xml 1325 1326 1325 1326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C8">8</xref>
###xml 1556 1557 1556 1557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C6">6</xref>
###xml 1558 1559 1558 1559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C9">9</xref>
###xml 1742 1744 1742 1744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C10">10</xref>
###xml 1745 1747 1745 1747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C15">15</xref>
###xml 1439 1445 <span type="species:ncbi:9913">cattle</span>
The lactase gene [LCT (MIM 603202)] is expressed in the intestinal epithelial cells and its protein product contributes to carbohydrate metabolism via digestion of the milk sugar lactose. The activity of the lactase enzyme in intestinal cells normally declines during childhood. Individuals with lactase non-persistence show varying degrees of abdominal pain, diarrhoea, bloating and gas formation after consumption of lactose-containing foods, in particular milk and other non-fermented dairy products. Molecular studies of lactose intolerance led to the identification of specific variations in a cis-regulatory element of the LCT gene resulting in lactase persistence (LP) which is an autosomal dominant condition (MIM 223100). The LP single-nucleotide polymorphism (SNP) most common among individuals of European descent (C/T-13910, rs4988235) was first identified by Enattah et al. (1) in Finnish lactose intolerance families. The T allele correlated perfectly with the LP phenotype of intestinal cells and functional studies have shown that the T allele is associated with the disrupted down-regulation of the LCT gene during childhood (2,3). The enhancer function of this mutation has also been shown in vitro (4,5). Subsequently, this region has yielded a spectrum of variants, some showing population specificity (6-8). These variants have been under strong positive selection regionally and seem to reflect independent events of cattle domestication, as exemplified by the two different allelic backgrounds of the Arabic and European LP alleles (6,9). The European LP allele has been associated with higher milk consumption in Finnish, Estonian and Austrian populations, one of which being the Finnish YF sample used in this study (10-15).
###end p 3
###begin p 4
We hypothesized that since lactase non-persistent individuals are on a more restricted diet when compared with the LP individuals, this may have an impact on body mass index (BMI) and/or height. Lactose-containing dairy products are often high in energy content potentially increasing daily calorie intake, and for the lactase non-persistent, they may cause diarrhoea which can prevent the absorption of nutrients. Further, milk is rich in calcium, required for skeletal growth.
###end p 4
###begin p 5
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C16">16</xref>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C17">17</xref>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C18">18</xref>
###xml 807 809 807 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C19">19</xref>
###xml 810 812 810 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C22">22</xref>
BMI is calculated as weight in kilograms divided by the square of height in meters. BMI has been studied extensively due to the health effects of obesity and its relative ease of measurement. Excessive weight increases the risk of type II diabetes, coronary artery disease and hypertension, and is associated with many forms of cancer along with adverse social and psychological consequences (16,17). The need for more effective clinical strategies has become evident with the increasing prevalence of obesity in recent years (18). This has put pressure on genetic studies to find variants responsible for differences in response to positive energy balance. Recent genome-wide association studies (GWASs) have been able to show association between BMI and genetic variants in a total of 13 genomic regions (19-22). In this study, we show the association between genetically defined LP and BMI.
###end p 5
###begin title 6
RESULTS
###end title 6
###begin p 7
###xml 544 550 544 550 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-13910</sub>
###xml 618 624 618 624 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-13910</sub>
###xml 765 766 765 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 802 806 802 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 816 817 813 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 848 849 845 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 885 889 882 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 899 900 893 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 962 963 956 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 999 1003 993 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1013 1014 1004 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1028 1029 1019 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1065 1069 1056 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1079 1080 1067 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1102 1103 1090 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1139 1143 1127 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1153 1154 1138 1139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1178 1179 1163 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP561TB1">1</xref>
The effect of LP was evaluated in five Finnish representative population cohorts, all non-ascertained for BMI or height: The North Finland Birth Cohort 1966 (NFBC 1966), The Health 2000 Health Examination Survey (Health2000), The Cardiovascular Risk of Young Finns Study (YF), the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) study and the FINRISK which is a cross-sectional population survey targeting coronary risk factors collected every 5 years. The cohort-specific analyses were performed on corrected phenotype comparing the C-13910 allele homozygotes (lactase non-persistent, CC genotypes) against T-13910 allele carriers (LP, CT and TT genotypes) using linear regression. There was evidence for association with BMI and the LP in the NFBC 1966 (n = 5498, C allele frequency = 0.39, beta = -0.11, P = 0.002) and in ATBC cohorts (n = 2126, C allele frequency = 0.40, beta = -0.12, P = 0.04) and the same direction of association in Health2000 (n = 5320, C allele frequency = 0.42, beta = -0.06, P = 0.10), YF (n = 2165, C allele frequency = 0.42, beta = -0.04, P = 0.51) and FINRISK (n = 2265, C allele frequency = 0.45, beta = -0.09, P = 0.09) cohorts. Table 1 summarizes the cohort-specific analyses.
###end p 7
###begin p 8
Cohort-specific results
###end p 8
###begin p 9
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 102 108 102 108 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-13910</sub>
###xml 126 130 126 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
n, number of individuals; SE, standard error; LP, lactase persistence determined by the frequency of T-13910 allele carriers, beta (SE) are from the association analysis between standardized BMI and LP (rs4988235 CC against CT/TT genotypes). The nationwide Finnish cohort analyses of Health2000, YF and FINRISK were corrected for region of residence (Southwest, East and Oulu region), age and sex effects in Health2000 cohort and FINRISK cohort, with sex in NFBC 1966 cohort, with age in ATBC cohort, with age and birth place coordinates in BWHHS, with sex and age in ERF study (family-based sample), with age, sex and first 10 principal components in Rotterdam and KORA studies. Outliers deviating more than three standard deviations were removed from the analyses.
###end p 9
###begin p 10
###xml 118 122 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 132 133 129 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 144 146 141 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 200 201 197 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 419 420 404 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP561F1">1</xref>
###xml 303 309 <span type="species:ncbi:9606">person</span>
The CC genotype was associated with decreased BMI compared with CT/TT genotypes in the meta-analysis of 17 374 Finns (beta = -0.08, P = 1.5 x 10-5). The individuals carrying the LP allele had 0.3 kg/m2 higher BMI than the non-persistent individuals which corresponds to approximately1 kg for an average person. The single study results from linear regression and the meta-analyses are summarized as a forest plot (Fig. 1).
###end p 10
###begin p 11
The forest plot of the linear regression analyses and meta-analyses.
###end p 11
###begin p 12
###xml 69 70 69 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 79 83 79 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 93 94 90 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 105 107 102 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 172 173 169 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 182 186 179 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 196 197 190 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 276 277 270 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
We also performed a sex-specific meta-analysis and found that males (n = 9739, beta = -0.09, P = 1.6 x 10-4) had somewhat higher effect estimate in the model than females (n = 7635, beta = -0.06, P = 0.02), but there was no robust statistical evidence of a gender difference (P = 0.6).
###end p 12
###begin p 13
###xml 71 72 71 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 97 98 97 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 610 611 610 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 754 755 754 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 774 775 774 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 876 877 876 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 892 893 892 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 913 914 913 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1164 1168 1164 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1189 1193 1186 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1203 1204 1197 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1283 1287 1277 1278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1297 1298 1288 1289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Genome-wide SNP data were available for two of the cohorts, NFBC 1966 (n = 4911) and Health2000 (n = 2145, metabolic syndrome case-control sample). The first 14 eigenvectors from the principal components analysis of the GWA SNP panel explained relatively the largest proportion of the variance of the principal components in the NFBC 1966; therefore, we tested for the correlation of BMI between these eigenvectors in both genome-wide SNP data sets. We used linear regression to evaluate evidence of correlation between the eigenvectors and BMI. No correlation was found in either NFBC 1966 or the Health2000 (P > 0.05). We tested for the correlation of LP and eigenvectors using logistic regression since the response variable was dichotomous. The 5th (P = 0.02) and 10th (P = 0.01) principal components showed most evidence of correlation with LP in NFBC 1966, and the 2nd (P = 0.02), 7th (P = 0.008) and 12th (P = 0.008) eigenvectors with LP in Health2000. Including these eigenvectors as covariates in the linear regression did not change association between BMI and LP in the NFBC 1966 data or in the Health2000 subsample. In NFBC 1966, the linear regression beta changed marginally (beta = -0.12, P = 0.003), and in the Health2000 subsample, the effect size remained the same (beta = -0.13, P = 0.03). Since the Health2000 subsample was ascertained for metabolic syndrome, we tested for the effect in both cases and controls separately, and found the linear regression beta to be equal in both groups.
###end p 13
###begin p 14
###xml 9 14 9 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 17 19 17 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C19">19</xref>
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 111 114 111 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LCT</italic>
###xml 119 122 119 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 208 211 208 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 246 247 246 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 308 311 308 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 368 369 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 378 379 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 390 392 390 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 401 404 401 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
Frayling et al. (19) have shown that the FTO rs9939609 A allele is positively associated with BMI. We had both LCT and FTO genotypes available in NFBC 1966 cohort for 4955 individuals. The difference between FTO AA and TT homozygotes was 0.5 kg/m2. We compared the proportion of variance in BMI explained by FTO and the proportion explained by LP. The additive model (n = 4955, P = 6.7 x 10-4) of the FTO gene association was found to explain 0.2% of the variance in BMI in the NFBC 1966 cohort. Similarly, the dominant effect of LP was found to account for 0.2% of the variance in BMI in this cohort.
###end p 14
###begin p 15
###xml 144 145 144 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 156 160 156 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 171 172 168 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 337 338 334 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 349 353 346 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 363 364 357 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 375 377 369 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
We tested for the association with height and LP marker but we did not find evidence of a meaningful association in the meta-analysis in Finns (n = 17 374, beta = -0.004, P = 0.41). We also performed a weight analysis which-as expected, given the association with BMI but lack of association with height-demonstrated robust association (n = 17 374, beta = -0.08, P = 1.4 x 10-5). Both height and weight analyses were performed in the same way as the BMI analyses.
###end p 15
###begin p 16
###xml 68 71 68 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LCT</italic>
###xml 273 274 273 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 318 319 318 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 330 332 330 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 551 552 551 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP561TB2">2</xref>
Since the initial GWASs have not identified this association in the LCT region, we tested the effect of using an additive model in the analyses instead of the correct dominant model and combined the results with meta-analysis. The additive model decreased the association (P = 0.001) compared with the dominant model (P = 1.5 x 10-5). We simulated the size of the power decrease resulting from using the incorrect additive model instead of the correct dominant model through bootstrapping. The results of this power comparison are summarized in Table 2.
###end p 16
###begin p 17
###xml 115 116 115 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 141 145 141 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 187 190 184 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LCT</italic>
The results of power calculation for using the additive model instead of correct dominant model where sample size (n = 17 374), effect size (beta = -0.082) and MAF (0.39) the same as the LCT variant had in combined Finnish sample of this study
###end p 17
###begin p 18
###xml 97 101 97 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 202 203 199 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 213 217 210 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
We performed a dominance deviation test from additivity in each cohort separately and pooled the beta-estimates with meta-analysis. The dominance term suggested that we could reject the additive model (P = 0.001, beta = 0.047).
###end p 18
###begin p 19
###xml 167 168 167 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 170 171 170 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 180 184 180 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 194 195 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 556 560 553 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 571 572 565 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 581 582 575 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 708 712 702 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 722 723 713 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 732 733 723 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 951 955 942 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 964 965 952 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 974 975 962 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1082 1086 1070 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1097 1098 1082 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1109 1110 1094 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 46 51 <span type="species:ncbi:9606">Women</span>
The linear regression analysis of the British Women's Heart and Health Study (BWHHS) showed that the difference between the LP and lactase non-persistent was 0.30 kg/m2 (n = 3109, beta = -0.06, P = 0.4, C allele frequency = 0.25) which is in line with our finding in the Finnish population but underpowered due to smaller sample size. The Dutch analysis was performed with the Erasmus Rucphen Family (ERF) study with extended pedigrees and Rotterdam study. The effect size estimate from the family data was again in line with the Finnish and British data (beta = -0.082, n = 1952, P = 0.16, C allele frequency = 0.32) but the population-based Rotterdam study sample did not provide evidence for association (beta = -0.02, n = 5745, P = 0.69, C allele frequency = 0.29) and showed smaller effect size. The German analysis was performed with KORA S3 and KORA S4 study samples. The effect size was not in the same direction in the combined KORA samples (beta = 0.04, n = 3333, P = 0.20, C allele frequency = 0.36). We combined the effect sizes of non-Finnish samples in meta-analysis (beta = -0.019, n = 14 346, P = 0.24) which did not prove to be significant.
###end p 19
###begin p 20
###xml 268 269 268 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 269 270 269 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Since we had the rs4988235 genotyped for individuals in Health2000 subsample and NFBC 1966 and additionally we had genome-wide SNP data, we were able to impute the marker and compare the imputed genotypes with genotyped ones. The imputation quality score was 0.91 and r2 was 0.81. The phenotype-defining C/C genotype had 23% discordance between the imputed versus genotyped calls. Of the 1060 C/C calls in the genotyped data, 245 were not defined C/C in the imputed data. In 15 cases, the imputation gave C/C genotype where the genotyped individuals had C/T genotype. In total, 11% of all calls were discordant between imputed and genotyped data.
###end p 20
###begin p 21
###xml 109 113 109 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 123 124 120 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 135 137 132 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 274 275 271 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 275 276 272 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 297 298 294 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Q</italic>
###xml 331 332 328 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 461 462 458 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP561F1">1</xref>
###xml 477 478 474 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP561TB1">1</xref>
We combined the effect sizes of all nine cohorts in meta-analysis. The association with BMI remained robust (beta = -0.06, P = 7.9 x 10-5) in the combined analysis of 31 720 European individuals. There was some evidence of heterogeneity in the meta-analysis of all samples (I2 = 10), although the Q statistics was not significant (P = 0.35). Results of the individual study linear regression analyses and the meta-analyses are summarized as a forest plot (Fig. 1) and in Table 1.
###end p 21
###begin title 22
DISCUSSION
###end title 22
###begin p 23
###xml 96 97 96 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 108 110 108 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 170 173 170 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LCT</italic>
###xml 177 183 177 183 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-13910</sub>
###xml 247 253 247 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C23">23</xref>
###xml 359 365 359 365 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-13910</sub>
###xml 750 753 750 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LCT</italic>
###xml 757 763 757 763 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-13910</sub>
###xml 867 869 867 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C24">24</xref>
###xml 1291 1296 1291 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1299 1301 1299 1301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C25">25</xref>
###xml 1701 1703 1701 1703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C26">26</xref>
###xml 1975 1976 1975 1976 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 1976 1977 1976 1977 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 2165 2166 2165 2166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP561F1">1</xref>
###xml 2254 2255 2254 2255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2266 2268 2266 2268 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 2295 2296 2295 2296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2390 2391 2390 2391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
In this study, we present novel evidence of association between genetically defined LP and BMI (P = 7.9 x 10-5) in 31 720 individuals from four European populations. The LCT C/T-13910 marker frequency shows strong population differences. Campbell et al. (23), sampling from an European American population, tested for an association between height and the C/T-13910 marker and found robust association between the marker and height if they did not correct for the ancestral origin of the samples. After the correction for ancestral origin, the association was considerably attenuated, thus indicating that the association was most likely an incidental reflection of population stratification of this variant. Similar generation of a link between the LCT C/T-13910 marker and self-rated health has been shown to be due to population stratification in a British study (24). We tested for the association with height and the LP marker and we did not find this marker to be associated with height. The NFBC 1966 cohort and a subset of the Health2000 cohort had genome-wide SNP data available with which we could assess the effect of population substructure. The first two principal components describe the geographical origin of the individuals in NFBC 1966 cohort, as has been shown by Jakkula et al. (25). We showed that none of the first 14 eigenvectors had a material effect on the association analysis in both the regional NFBC 1966 sample and a country-wide Health2000 subsample, which strongly suggests that the association was not due to population stratification. The best evidence which would exclude the effect of stratification came from the ERF study from the Netherlands. Although the QTDT (26) analyses were not significant, the effect size was in line with the population-based studies which is a good indicator that the population-based results were not due to stratification. All five Finnish study cohorts showed the same trend of increased BMI (heterogeneity I2 = 0), although the association was not conventionally significant in all cohorts individually. However, after combining the cohorts in the meta-analysis, the association was robust (Fig. 1). We showed that the increase in BMI was mediated through the increase in body weight (P = 1.4 x 10-5) but not through stature (P = 0.41). The non-Finnish population samples did not replicate the association significantly (P = 0.24). The marker was genotyped in the British study which showed similar effect size than the Finnish sample. The cohorts which show smaller effect size have all been imputed. In our Finnish sample, we found that the imputation of this region proves to be difficult and the erroneous genotypes concentrate on the phenotype-defining genotype. This effect is shown in Finnish population and it is not possible to assess whether it is the same case in our European replication cohorts. The ERF study is more robust for this kind of error since it benefits from the family structure in the imputation. Should the same phenomenon exist in the imputed European replication samples, the effect size would be a drastic underestimate and would explain why the European replication cohorts show smaller effect size.
###end p 23
###begin p 24
###xml 7 10 7 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 212 215 212 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
We had FTO genotypes available for the NFBC 1966 cohort and were able to compare the effect size of these two variants. The LP variant had a similar effects size and explained a similar proportion of variance to FTO in this cohort.
###end p 24
###begin p 25
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 24 26 24 26 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C27">27</xref>
###xml 105 106 105 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 117 119 117 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 159 160 159 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 160 161 160 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 170 171 170 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 489 490 489 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 533 538 533 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
A GWAS by Meyre et al. (27) has previously shown association in this region. They showed an association (P = 9.2 x 10-4) with a marker which is in LD (HapMap, r2 = 0.58, D' = 0.80, rs2011946) with the LP variant and BMI in 135 obese adults and 794 lean adults of French origin. It is not possible to determine whether this association was due to stratification or not. They could not show association in an independent population-based cohort possibly because the cohort was underpowered (n = 4417). The effect in the study by Meyre et al. was in the same direction as in our study in all of the three tested adult cohorts. Any further comparison is not possible since they did not have the same marker genotyped.
###end p 25
###begin p 26
###xml 448 450 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C19">19</xref>
###xml 451 453 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C22">22</xref>
###xml 488 489 488 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 489 490 489 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 501 504 501 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LCT</italic>
###xml 508 514 508 514 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-13910</sub>
###xml 721 723 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C28">28</xref>
###xml 947 948 947 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP561TB2">2</xref>
###xml 1067 1068 1067 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1093 1094 1093 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1105 1107 1105 1107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 1560 1562 1560 1562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C24">24</xref>
###xml 1830 1832 1830 1832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C29">29</xref>
###xml 2023 2025 2023 2025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C10">10</xref>
###xml 2026 2028 2026 2028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C11">11</xref>
There are several possible explanations as to why the LP association with BMI may have remained undetected in rest of the GWA analyses. First, the functional variant is not included in any currently used SNP arrays and the power has been reduced due to insufficient linkage disequilibrium (LD). The recently published GWASs were genotyped either by Affymetrix 5.0 or Illumina array which has less coverage in this area than the HumanHap 650 array (19-22). We found that the strongest LD (r2) with the LCT C/T-13910 and any marker within 500 000 bp in the HapMap CEPH (Utah residents with ancestry from northern and western Europe) sample included in the Illumina HumanHap 650 or Affymetrix 5.0 array was 0.78 (rs309160) (28). Second, the first four GWASs had used an additive model, which given the dominant inheritance model of LP and based on what we show here is inappropriate, and results in a considerable decrease in power as shown in Table 2. The strength of evidence of association was also reduced in our data set when the incorrect model was used (additive P = 0.001 versus dominant P = 1.5 x 10-5). Third, the imputation accuracy might be compromised in this region as was shown by our Finnish sample. Together, the incomplete tagging or inaccurate imputation combined with the use of an inappropriate genetic model may explain why this association has remained undetected. Furthermore, the association of LP with milk consumption varies between populations, being stronger in settings of intermediate allele frequency than when one allele is rare (24). One cannot reject cultural influences on milk consumption overriding the generally rather minor discomfort consequent on milk ingestion by non-persistent individuals and lead to the expectation that the association of LP genotype with BMI will be context-specific (29). The effect size of this variant may be large in Finland where dairy product consumption is very common and there is a correlation with liquid dairy product consumption and the LP variant (10,11). Further, the effect size may have been overestimated in the initial Finnish discovery sample.
###end p 26
###begin p 27
###xml 754 757 754 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LCT</italic>
###xml 774 779 <span type="species:ncbi:9606">human</span>
The mechanism by which LP affects body composition may be related to the more restricted diet the lactase non-persistent individuals may choose or perhaps the negative symptoms such as diarrhoea after using lactose-containing food products play some role. This finding may also reflect the positive selection the LP allele has been subject to in recent history. Our study highlights the fact that the recent GWASs have not exhaustively revealed the common variants affecting BMI. Although explanation at a functional level is a matter for future studies and finding is not significant in the GWAS established genome-wide level of significance, we propose that the European variant behind LP, and perhaps other variants affecting the regulatory region of LCT, contributes to human obesity.
###end p 27
###begin title 28
MATERIALS AND METHODS
###end title 28
###begin title 29
Study samples
###end title 29
###begin p 30
###xml 222 223 222 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP561TB3">3</xref>
###xml 1763 1768 1756 1761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1771 1773 1764 1766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C30">30</xref>
###xml 2103 2105 2096 2098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C31">31</xref>
###xml 2106 2108 2099 2101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C32">32</xref>
###xml 39 51 <span type="species:ncbi:9606">participants</span>
###xml 937 949 <span type="species:ncbi:9606">participants</span>
###xml 1482 1490 <span type="species:ncbi:9606">children</span>
###xml 1807 1819 <span type="species:ncbi:9606">participants</span>
###xml 2045 2057 <span type="species:ncbi:9606">participants</span>
###xml 2111 2116 <span type="species:ncbi:9606">Women</span>
###xml 2202 2207 <span type="species:ncbi:9606">Women</span>
Informed consent was obtained from all participants and study was conducted according to the principles expressed in the Declaration of Helsinki and the studies were reviewed and accepted by local ethics committees. Table 3 shows the cohort characteristics. More detailed description of the study cohorts can be found at the National Biobank of Finland website (see Web Resources) and from the University of Turku website (YF cohort, see Web Resources). In brief, the NFBC 1966 includes individuals born in the Northernmost provinces of Finland with expected date of birth in 1966 who underwent a health examination at age 31. The Health2000 was conducted in 2000 to explore the health of the Finnish population. Our Health2000 cohort consists of individuals aged 30 and over. The ATBC study was initially collected to test whether alpha-tocopherol and beta-carotene supplements would reduce the incidence of lung and other cancers. The participants were male smokers aged 50-69 years from South-western Finland. FINRISK is a cross-sectional population survey targeting coronary risk factors collected every 5 years. The current study contains individuals recruited during years 1992 and 1997 and were selected for cardiovascular study. The YF is a population-based prospective cohort study conducted at five university departments of medical schools in Finland (i.e. Turku, Helsinki, Kuopio, Tampere and Oulu), with the aim of studying the levels of cardiovascular risk factors in children and adolescents in different parts of the country. The latest follow-up was conducted in 2007. The present analysis included 2165 subjects with data on height, weight and the gene variant. The study and data collection protocols have been described in detail by Raitakari et al. (30). The Health2000, YF and FINRISK participants were collected across Finland, whereas NFBC 1966 was sampled within the Northern region and the ATBC within the South-western region of Finland. The same analyses were performed in the BWHHS. Full details of the selection of participants and measurements have been reported earlier (31,32). Women aged 60-79 years were randomly selected from primary care lists in 23 British towns. Women were recognized as non-white in the BWHHS and excluded from further analyses.
###end p 30
###begin p 31
Sex-specific cohort characteristics
###end p 31
###begin p 32
###xml 65 66 65 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
NA, not available; SD, standard deviation; BMI, body mass index; n, number of individuals.
###end p 32
###begin p 33
###xml 45 46 45 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 286 291 286 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C33">33</xref>
The ERF study is an extended-pedigree study (n = 2700) focused on the identification of quantitative traits loci related to neuropsychiatric, cardiovascular, endocrinological, ophthalmological and musculoskeletal disorders. The ERF sample has been described in more detail by Aulchenko et al. (33).
###end p 33
###begin p 34
###xml 21 23 21 23 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C34">34</xref>
###xml 93 100 <span type="species:ncbi:9606">persons</span>
###xml 477 488 <span type="species:ncbi:9606">participant</span>
###xml 612 624 <span type="species:ncbi:9606">participants</span>
The Rotterdam study (34) is an ongoing prospective, population-based cohort study among 7983 persons aged 55 years and older, living in Ommoord, a district of Rotterdam, The Netherlands. The study was designed to investigate the incidence and determinants of chronic disabling diseases. The study is composed of an outbred ethnically homogeneous population of Dutch Caucasian origin. Rationale and design have been described previously. Informed consent was obtained from each participant, and the Medical Ethics Committee of the Erasmus Medical Centre Rotterdam approved the study. At baseline (1990-1993), all participants were interviewed and underwent extensive physical examination. These examinations were performed according to the same protocol at the second follow-up (1997-1999).
###end p 34
###begin p 35
###xml 71 76 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C35">35</xref>
The KORA [Cooperative Health Research in the Augsburg Region; Wichmann et al. (35)] studies are population-based samples from the general population living in the region of Augsburg, Southern Germany. The KORA S3 survey (4856 subjects, response 75%) has been examined in the years 1994-1995. The KORA S4 survey was conducted in 1999-2001. The KORA S3 and S4 samples do not overlap. The study has been approved by the local ethical committee. Genome-wide data are available from Affymetrix 500K chips in KORA S3 and Affymetrix 6.0 chips in KORA S4.
###end p 35
###begin title 36
Methods
###end title 36
###begin p 37
###xml 45 48 45 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LCT</italic>
###xml 52 58 52 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-13910</sub>
###xml 341 344 341 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LCT</italic>
###xml 348 354 348 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-13910</sub>
###xml 523 526 523 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LCT</italic>
###xml 530 536 530 536 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-13910</sub>
###xml 861 862 861 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 878 879 878 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 892 893 892 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 908 909 908 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 930 931 930 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 999 1002 999 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LCT</italic>
###xml 1006 1012 1006 1012 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-13910</sub>
###xml 1412 1413 1412 1413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 1413 1414 1413 1414 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1451 1452 1451 1452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 1452 1453 1452 1453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1705 1706 1705 1706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1720 1721 1720 1721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1747 1748 1747 1748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1766 1767 1766 1767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1785 1786 1785 1786 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
In Finland, the C allele homozygosity of the LCT C/T-13910 polymorphism (rs4988235) serves as a diagnostic marker for lactase non-persistence, whereas T homozygotes and heterozygotes can be classified as LP. We tested this SNP in a set of representative population cohorts and measured its potential association with BMI and height. The SNP LCT C/T-13910 was genotyped using iPlex assay on the MassARRAY System (Sequenom, San Diego, CA, USA) using standard protocols in a total of 17 374 Finnish individuals. The YF cohort LCT C/T-13910 genotyping was performed by using the 5'-nuclease assay and fluorogenic, allele-specific, TaqMan probes (Applied Biosystems, Foster City, CA, USA) and primers, with the ABI Prism 7000 sequence detection system (Applied Biosystems). The genotype frequencies followed Hardy-Weinberg equilibrium (HWE) in all five cohorts (YF, P = 0.814; ATBC, P = 0.84; FR, P = 0.77; NFBC, P = 0.93; Health2000, P = 0.54) and call rate was >95% in all samples. BWHHS genotypes for LCT C/T-13910 (rs4988235) were generated using the KASPar chemistry which is a competitive allele-specific PCR SNP genotyping system using FRET quencher cassette oligos using standard protocols. The rs4988235 marker was imputed to the ERF, Rotterdam and KORA studies. The genetic data for ERF, the Rotterdam study and KORA S4 was imputed using MACH with HAPMAP rel 22 CEU build 36 as a reference (ERF imputation, r2 = 0.94, Rotterdam imputation study, r2 = 0.92, KORA S4 observed versus expected variance = 0.89), whereas KORA S3 was imputed with MACH based on HAPMAP rel 21 build 35 (observed versus expected variance = 0.91). The genotype frequencies followed HWE in all four non-Finnish cohorts (BWHHS, P = 0.88; ERF, P = 0.23; Rotterdam study, P = 0.09; KORA S3, P = 0.75; KORA S4, P = 0.27).
###end p 37
###begin p 38
The association analyses were performed in parallel by three collaborating groups, hence NFBC 1966 and Health2000 were analysed with PLINK 1.04, FINRISK, KORA and ATBC cohorts were analysed with R, and YF and Rotterdam study cohort with SPSS, using linear regression. The ERF study was analysed using QTDT.
###end p 38
###begin p 39
###xml 12 18 12 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 20 22 20 22 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C36">36</xref>
###xml 1237 1239 1237 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C26">26</xref>
###xml 630 633 <span type="species:ncbi:9606">men</span>
Lahti-Koski et al. (36) have shown that there are no regional differences in BMI within Finland in males, but a slight difference in females between southern and western Finland. Therefore, we corrected the nationwide Health2000, YF and FINRISK analyses for the area of residence (Southwest, East and Northern Finland). The NFBC 1966 cohort was collected from Northern Finland and ATBC from southwest Finland, and therefore, no regional correction was applied. The phenotypes were corrected for age and sex effects in Health2000, YF and FINRISK cohorts, with sex in NFBC 1966 cohort (all 31 years old) and age in ATBC cohort (all men). BMI outliers deviating more than three standard deviations from the mean within a cohort were removed prior to analysis, resulting in approximately normal distribution (kurtosis and skewness both between -1 and 1). The Rotterdam study and KORA were corrected for sex, age and first 10 principal components from the genome-wide data and outliers deviating more than four standard deviations from principal components or three standard deviations from standardized corrected phenotype means were removed. The ERF cohort was corrected for sex and age. The family-based analyses were performed with QTDT (26). The association method was orthogonal association which is very robust to stratification. Dominance effect was included in the analysis model.
###end p 39
###begin p 40
The meta-analysis was performed by pooling the beta-estimates and standard errors from the individual studies using the inverse variance method.
###end p 40
###begin p 41
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C37">37</xref>
We had genome-wide SNP data (Illumina HumanHap 370) and phenotype data available for 4911 individuals from the NFBC 1966 cohort. Similarly, we had genome-wide SNP data (llumina HumanHap 610) available for a subset of the Health2000 cohort (2145 individuals) ascertained for matched case-control study for metabolic syndrome. We tested for hidden population substructure by performing a principal components analysis using EIGENSOFT (37). The imputation of the marker in these cohorts was performed with MACH using phased HAPMAP rel 22 CEU build 36 as a reference.
###end p 41
###begin p 42
###xml 202 206 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 234 237 231 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LCT</italic>
The power calculations were performed via bootstrapping. We performed 10 000 simulations where we simulated a sample of 17 374 individuals where the minor allele frequency (MAF = 0.39) and effect size (beta = -0.082) were the same as LCT variant found in this study. Each sample was analysed with both additive and dominant models. The simulations were performed with R.
###end p 42
###begin p 43
The dominance deviation test was performed by fitting jointly the additive term and a heterozygote indicator.
###end p 43
###begin p 44
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP561C38">38</xref>
The gender interaction analysis was performed by using the meta-analysis summary statistics. The method is described further in a book by Hardy (38).
###end p 44
###begin title 45
WEB RESOURCES
###end title 45
###begin p 46
###xml 29 59 29 59 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="http://www.nationalbiobanks.fi">http://www.nationalbiobanks.fi</uri>
###xml 87 128 87 128 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="http://med.utu.fi/cardio/youngfinnsstudy/">http://med.utu.fi/cardio/youngfinnsstudy/</uri>
###xml 164 185 164 185 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="http://www.hapmap.org">http://www.hapmap.org</uri>
National Biobank of Finland: http://www.nationalbiobanks.fi; Description of YF cohort: http://med.utu.fi/cardio/youngfinnsstudy/; The International HapMap Project: http://www.hapmap.org.
###end p 46
###begin title 47
FUNDING
###end title 47
###begin p 48
###xml 67 86 67 86 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">European Commission</funding-source>
###xml 104 122 104 122 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">QLG1-CT-2000-01643</award-id>
###xml 204 219 204 219 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NHLBI, Stampeed</funding-source>
###xml 304 313 304 313 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NIH/NHLBI</funding-source>
###xml 313 330 313 330 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1-R01-HL087679-01</award-id>
###xml 358 384 358 384 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Finnish Culture Foundation</funding-source>
###xml 407 488 407 488 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sigrid Juselius Foundation and the Finnish Foundation for Cardiovascular Research</funding-source>
###xml 525 703 525 703 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Academy of Finland Centre of Excellence in Complex Disease Genetics, the Biocentrum Helsinki Foundation, Helsinki, Finland, and the Finnish Foundation for Cardiovascular Research</funding-source>
###xml 737 761 737 761 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">US Public Health Service</funding-source>
###xml 772 815 772 815 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N01-CN-45165, N01-RC-45035 and N01-RC-37004</award-id>
###xml 825 891 825 891 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">National Cancer Institute, Department of Health and Human Services</funding-source>
###xml 937 961 937 961 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Emil Aaltonen Foundation</funding-source>
###xml 974 992 974 992 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Academy of Finland</funding-source>
###xml 994 1016 994 1016 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">grants 53392 and 34316</award-id>
###xml 1023 1275 1023 1275 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Social Insurance Institution of Finland, the Turku University Foundation, the Juho Vainio Foundation, the Finnish Foundation of Cardiovascular Research, the Finnish Cultural Foundation, and the Tampere and Turku University Central Hospital Medical Fund</funding-source>
###xml 1504 1579 1504 1579 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helmholtz Zentrum M&#252;nchen&#8212;National Research Center for Environmental Health</funding-source>
###xml 1604 1897 1604 1897 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria. Part of this work was financed by the German National Genome Research Network (NGFN-2 and NGFNPlus: 01GS0823) and within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ</funding-source>
###xml 877 882 <span type="species:ncbi:9606">Human</span>
Northern Finland Birth Cohort 1966 (NFBC 1966) is supported by the European Commission; contract number QLG1-CT-2000-01643, Biocenter Oulu, University of Oulu, Finland, and the Academy of Finland, and by NHLBI, Stampeed (Genetics of cardiovascular risk factors in large founder population birth cohorts) NIH/NHLBI1-R01-HL087679-01. V.A. was supported by the Finnish Culture Foundation. V.S. is supported by Sigrid Juselius Foundation and the Finnish Foundation for Cardiovascular Research. L.P. and K.S. are supported by the Academy of Finland Centre of Excellence in Complex Disease Genetics, the Biocentrum Helsinki Foundation, Helsinki, Finland, and the Finnish Foundation for Cardiovascular Research. The ATBC study was supported by US Public Health Service contracts N01-CN-45165, N01-RC-45035 and N01-RC-37004 from the National Cancer Institute, Department of Health and Human Services. The Young Finns cohort was supported by the Emil Aaltonen Foundation (T.L.), the Academy of Finland (grants 53392 and 34316), the Social Insurance Institution of Finland, the Turku University Foundation, the Juho Vainio Foundation, the Finnish Foundation of Cardiovascular Research, the Finnish Cultural Foundation, and the Tampere and Turku University Central Hospital Medical Fund. We would like to acknowledge the International HapMap Consortium for the linkage disequilibrium data. The KORA research platform (KORA: Kooperative Gesundheitsforschung in der Region Augsburg) was initiated and financed by the Helmholtz Zentrum Munchen-National Research Center for Environmental Health, which is funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria. Part of this work was financed by the German National Genome Research Network (NGFN-2 and NGFNPlus: 01GS0823) and within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. Funding to pay the Open Access Charge was provided by Wellcome Trust Sanger Institute.
###end p 48
###begin title 49
ACKNOWLEDGEMENTS
###end title 49
###begin p 50
We warmly thank all the Finnish volunteers who participated in the studies. Thanks are due to Siv Knaappila and Minna Suvela for excellent laboratory work.
###end p 50
###begin p 51
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of Interest statement</italic>
Conflict of Interest statement. None declared.
###end p 51
###begin title 52
REFERENCES
###end title 52
###begin article-title 53
Identification of a variant associated with adult-type hypolactasia
###end article-title 53
###begin article-title 54
Transcriptional downregulation of the lactase (LCT) gene during childhood
###end article-title 54
###begin article-title 55
Correlation of intestinal disaccharidase activities with the C/T-13910 variant and age
###end article-title 55
###begin article-title 56
An upstream polymorphism associated with lactase persistence has increased enhancer activity
###end article-title 56
###begin article-title 57
###xml 67 75 67 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 98 101 98 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
Lactase persistence DNA variant enhances lactase promoter activity in vitro: functional role as a cis-regulatory element
###end article-title 57
###begin article-title 58
###xml 65 70 <span type="species:ncbi:9606">human</span>
Independent introduction of two lactase-persistence alleles into human populations reflects different history of adaptation to milk culture
###end article-title 58
###begin article-title 59
A novel polymorphism associated with lactose tolerance in Africa: multiple causes for lactase persistence?
###end article-title 59
###begin article-title 60
###xml 25 30 <span type="species:ncbi:9606">human</span>
Convergent adaptation of human lactase persistence in Africa and Europe
###end article-title 60
###begin article-title 61
Genetic signatures of strong recent positive selection at the lactase gene
###end article-title 61
###begin article-title 62
The effects of adult-type hypolactasia on body height growth and dietary calcium intake from childhood into young adulthood: a 21-year follow-up study-the Cardiovascular Risk in Young Finns Study
###end article-title 62
###begin article-title 63
###xml 98 101 <span type="species:ncbi:9606">men</span>
Molecularly defined lactose malabsorption, peak bone mass and bone turnover rate in young Finnish men
###end article-title 63
###begin article-title 64
Genetic predisposition for adult lactose intolerance and relation to diet, bone density, and bone fractures
###end article-title 64
###begin article-title 65
Molecularly-defined lactose malabsorption, milk consumption and anthropometric differences in adult males
###end article-title 65
###begin article-title 66
Lactase non-persistence and milk consumption in Estonia
###end article-title 66
###begin article-title 67
Adult-type hypolactasia and calcium availability: decreased calcium intake or impaired calcium absorption?
###end article-title 67
###begin article-title 68
The disease burden associated with overweight and obesity
###end article-title 68
###begin article-title 69
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults
###end article-title 69
###begin article-title 70
Prevalence of overweight and obesity in the United States, 1999-2004
###end article-title 70
###begin article-title 71
A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity
###end article-title 71
###begin article-title 72
Common variants near MC4R are associated with fat mass, weight and risk of obesity
###end article-title 72
###begin article-title 73
Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity
###end article-title 73
###begin article-title 74
Six new loci associated with body mass index highlight a neuronal influence on body weight regulation
###end article-title 74
###begin article-title 75
Demonstrating stratification in a European American population
###end article-title 75
###begin article-title 76
Lactase persistence-related genetic variant: population substructure and health outcomes
###end article-title 76
###begin article-title 77
The genome-wide patterns of variation expose significant substructure in a founder population
###end article-title 77
###begin article-title 78
A general test of association for quantitative traits in nuclear families
###end article-title 78
###begin article-title 79
Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations
###end article-title 79
###begin article-title 80
The International HapMap Project
###end article-title 80
###begin article-title 81
Lactose intolerance symptoms assessed by meta-analysis: a grain of truth that leads to exaggeration
###end article-title 81
###begin article-title 82
Cohort profile: the cardiovascular risk in Young Finns Study
###end article-title 82
###begin article-title 83
###xml 91 96 <span type="species:ncbi:9606">women</span>
###xml 106 111 <span type="species:ncbi:9606">Women</span>
Geographical variation in cardiovascular disease, risk factors, and their control in older women: British Women's Heart and Health Study
###end article-title 83
###begin article-title 84
###xml 121 126 <span type="species:ncbi:9606">women</span>
Socioeconomic position in childhood and adulthood and insulin resistance: cross-sectional survey using data from British women's heart and health study
###end article-title 84
###begin article-title 85
Linkage disequilibrium in young genetically isolated Dutch population
###end article-title 85
###begin article-title 86
The Rotterdam Study: 2010 objectives and design update
###end article-title 86
###begin article-title 87
KORA-gen-resource for population genetics, controls and a broad spectrum of disease phenotypes
###end article-title 87
###begin article-title 88
Mapping geographical variation in obesity in Finland
###end article-title 88
###begin article-title 89
Principal components analysis corrects for stratification in genome-wide association studies
###end article-title 89

